Bluejay Diagnostics Return on Tangible Equity 2020-2024 | BJDX
Current and historical return on tangible equity values for Bluejay Diagnostics (BJDX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Bluejay Diagnostics Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-12-31 | $-0.02B | $0.01B | -320.00% |
| 2024-09-30 | $-0.01B | $0.01B | -127.27% |
| 2024-06-30 | $-0.01B | $0.01B | -160.00% |
| 2024-03-31 | $-0.01B | $0.00B | -211.76% |
| 2023-12-31 | $-0.01B | $0.00B | -173.91% |
| 2023-09-30 | $-0.01B | $0.01B | -125.00% |
| 2023-06-30 | $-0.01B | $0.01B | -107.32% |
| 2023-03-31 | $-0.01B | $0.01B | -76.92% |
| 2022-12-31 | $-0.01B | $0.01B | -59.02% |
| 2022-09-30 | $-0.01B | $0.01B | -46.38% |
| 2022-06-30 | $-0.01B | $0.02B | -44.44% |
| 2022-03-31 | $-0.01B | $0.02B | -54.05% |
| 2021-12-31 | $0.00B | $0.02B | -63.16% |
| 2021-06-30 | $0.00B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.001B | $0.000B |
| Bluejay Diagnostics Inc. is a late-stage, pre-revenue medical device company. It focused on developing near-patient products for triage, diagnosis and monitoring of disease progression. Bluejay Diagnostics Inc. is based in ACTON, Mass. | |||